InsiderTrades

Form 4 for REGN Regeneron Pharmaceuticals

Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001708138-21-000080 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-09-15 2021-09-13 REGN Tessier-Lavigne Marc Dir S - Sale+OE $641.71 -12.8K 6,260 -67% -$8.18M
DM 2021-09-15 2021-09-13 REGN Tessier-Lavigne Marc Dir M - OptEx $273.67 +12.8K 14.8K +614% +$3.49M
DM 2021-09-15 2021-09-13 REGN Tessier-Lavigne Marc Dir M - OptEx $0.00 -12.8K 8,500 -60% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-13 S D 1,549 $643.33 4,711 D — — (F9) Represents volume-weighted average price of sales of 1,549 shares of Company stock on September 13, 2021 at prices ranging from $643.01 to $643.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
2 Common Common Stock 2021-09-13 S D 844 $644.52 3,867 D — — (F10) Represents volume-weighted average price of sales of 844 shares of Company stock on September 13, 2021 at prices ranging from $644.03 to $644.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
3 Common Common Stock 2021-09-13 S D 61 $645.21 3,806 D — — (F11) Represents volume-weighted average price of sales of 61 shares of Company stock on September 13, 2021 at prices ranging from $645.21 to $645.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
4 Common Common Stock 2021-09-13 S D 354 $646.24 3,452 D — — (F12) Represents volume-weighted average price of sales of 354 shares of Company stock on September 13, 2021 at prices ranging from $646.04 to $646.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
5 Common Common Stock 2021-09-13 S D 425 $647.39 3,027 D — — (F13) Represents volume-weighted average price of sales of 425 shares of Company stock on September 13, 2021 at prices ranging from $647.06 to $647.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
6 Common Common Stock 2021-09-13 S D 381 $648.25 2,646 D — — (F14) Represents volume-weighted average price of sales of 381 shares of Company stock on September 13, 2021 at prices ranging from $648.06 to $648.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
7 Common Common Stock 2021-09-13 S D 124 $649.35 2,522 D — — (F15) Represents volume-weighted average price of sales of 124 shares of Company stock on September 13, 2021 at prices ranging from $649.27 to $649.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
8 Common Common Stock 2021-09-13 S D 56 $650.33 2,466 D — —
9 Common Common Stock 2021-09-13 S D 249 $651.54 2,217 D — — (F16) Represents volume-weighted average price of sales of 249 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
10 Common Common Stock 2021-09-13 S D 139 $652.26 2,078 D — —
11 Common Common Stock 2021-09-13 M A 4,250 $273.67 6,328 D — —
12 Common Common Stock 2021-09-13 M A 4,250 $273.67 10,578 D — —
13 Common Common Stock 2021-09-13 M A 4,250 $273.67 14,828 D — —
14 Common Common Stock 2021-09-13 S D 952 $641.56 7,905 D — — (F7) Represents volume-weighted average price of sales of 952 shares of Company stock on September 13, 2021 at prices ranging from $641.01 to $641.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
15 Common Common Stock 2021-09-13 S D 981 $640.61 8,857 D — — (F6) Represents volume-weighted average price of sales of 981 shares of Company stock on September 13, 2021 at prices ranging from $640.18 to $640.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
16 Common Common Stock 2021-09-13 S D 1,260 $639.45 9,838 D — — (F5) Represents volume-weighted average price of sales of 1,260 shares of Company stock on September 13, 2021 at prices ranging from $639.00 to $639.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
17 Common Common Stock 2021-09-13 S D 2,098 $638.46 11,098 D — — (F4) Represents volume-weighted average price of sales of 2,098 shares of Company stock on September 13, 2021 at prices ranging from $638.00 to $638.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
18 Common Common Stock 2021-09-13 S D 816 $637.71 13,196 D — — (F3) Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $637.26 to $637.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
19 Common Common Stock 2021-09-13 S D 816 $636.64 14,012 D — — (F2) Represents volume-weighted average price of sales of 816 shares of Company stock on September 13, 2021 at prices ranging from $636.08 to $636.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
20 Common Common Stock 2021-09-13 S D 1,645 $642.54 6,260 D — — (F8) Represents volume-weighted average price of sales of 1,645 shares of Company stock on September 13, 2021 at prices ranging from $642.00 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
21 Derivative Non-Qualified Stock Option (right to buy) 2021-09-13 M D 4,250 $0.00 4,250 D $273.67 · — to 2024-01-02 4,250 Common Stock (F17) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
22 Derivative Non-Qualified Stock Option (right to buy) 2021-09-13 M D 4,250 $0.00 0 D $273.67 · — to 2024-01-02 4,250 Common Stock (F17) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
23 Derivative Non-Qualified Stock Option (right to buy) 2021-09-13 M D 4,250 $0.00 8,500 D $273.67 · — to 2024-01-02 4,250 Common Stock (F17) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.